Answers are grounded in this paper and cite their sources.
Prospective external validation shows promise in differentiating benign and malignant BI-RADS 4 lesions, suggesting improved decision-making.
The DCE-MRI kinetic heterogeneity-based nomogram is a promising tool to differentiate benign and malignant BI-RADS 4 breast lesions. Prospective external validation is warranted to confirm its potential for improving clinical decision-making and reducing unnecessary biopsies.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: